Medical Services

Multiple Myeloma is a type of blood cancer that develops in plasma cells, a specialized white blood cell responsible for producing antibodies that help fight infections. In this condition, abnormal plasma cells multiply uncontrollably within the bone marrow, crowding out healthy blood-forming cells and producing excessive amounts of abnormal proteins. These proteins can damage the kidneys and interfere with normal immune function.

Common symptoms include persistent bone pain, especially in the spine or ribs, fatigue, frequent infections, unexplained weight loss, weakness, and increased thirst due to high calcium levels caused by bone breakdown. Some patients may also experience anemia, fractures, or kidney dysfunction before diagnosis.

The exact cause of Multiple Myeloma remains unknown, although increasing age, family history, male gender, and exposure to certain chemicals or radiation may increase the risk. Diagnosis typically involves blood and urine tests, bone marrow biopsy marrow biopsy, imaging studiesgenetic analysis

Treatment depends on the stage of the disease and the patient's overall health. Common options include targeted therapy, immunotherapy, chemotherapy, corticosteroids, stem cell transplantation, and supportive treatments to strengthen bones and manage complications. Regular follow-up and timely treatment can help control disease progression, reduce symptoms, improve quality of life, and extend survival for many patients.